Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference

被引:15
作者
Afshar, Zeinab Mohseni [1 ]
Ebrahimpour, Soheil [2 ]
Javanian, Mostafa [2 ]
Koppolu, Veerendra [3 ]
Vasigala, Veneela Krishna Rekha [4 ]
Hasanpour, Amir Hossein [5 ]
Babazadeh, Arefeh [2 ]
机构
[1] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran
[2] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol, Iran
[3] Medimmune, Biopharmaceut Dev, Gaithersburg, MD 20878 USA
[4] NTR Univ Hlth Sci, Rangaraya Med Coll, Kakinada, India
[5] Babol Univ Med Sci, Student Res Comm, Babol, Iran
关键词
COVID-19; Middle East respiratory syndrome; Severe acute respiratory syndrome; Coronavirus; ACUTE RESPIRATORY SYNDROME; TRANSMISSION; EPIDEMIOLOGY;
D O I
10.4103/2221-6189.291283
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
SARS-CoV-2 is the causative agent of COVID-19. Since its outbreak in December 2019, COVID-19 has swept the globe. By 17 July 2020, the World Health Organization (WHO) had confirmed 13 119 239 cases and 573 752 deaths, and the numbers are still rising. Current evidence shows that COVID-19 is lower than severe acute respiratory syndrome and Middle East respiratory syndrome in terms of severity and mortality risk, although the infections are particularly more severe in patients with underlying medical conditions. The bulk of COVID-19 patients had close contact with confirmed cases, but an exact origin and specific transmission for COVID-19 are still unknown. As there is no approved antiviral treatment for COVID-19 infection, proper prevention and control practices are essential to control the infection. To have an insight view of COVID-19, we summarized and compared the etiology, clinical manifestations, diagnosis, treatment, and prevention measures of COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome.
引用
收藏
页码:194 / 199
页数:6
相关论文
共 45 条
[1]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[2]   Remdesivir as a possible therapeutic option for the COVID-19 [J].
Al-Tawfiq, Jaffar A. ;
Al-Homoud, Ali H. ;
Memish, Ziad A. .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
[3]  
Algaissi A, 2020, METHODS MOL BIOL, V2099, P99, DOI 10.1007/978-1-0716-0211-9_8
[4]   Evidence for Camel-to-Human Transmission of MERS Coronavirus [J].
Azhar, Esam I. ;
El-Kafrawy, Sherif A. ;
Farraj, Suha A. ;
Hassan, Ahmed M. ;
Al-Saeed, Muneera S. ;
Hashem, Anwar M. ;
Madani, Tariq A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) :2499-2505
[5]  
Cao B, 2020, NEW ENGL J MED, V382
[6]  
Cascella M, 2020, Features, Evaluation, And Treatment of Coronavirus (COVID-19)
[7]   Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses [J].
Chen, Jieliang .
MICROBES AND INFECTION, 2020, 22 (02) :69-71
[8]   New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? [J].
Devaux, Christian A. ;
Rolain, Jean-Marc ;
Colson, Philippe ;
Raoult, Didier .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)
[9]  
Di Gennaro Francesco, 2020, INT J ENV RES PUB HE, V17, P2690
[10]  
Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, CHIN J EPIDEMIOL